BRUKER CORPORATION Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation
BRUKER CORPORATION (BRKR) reported Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation of $3.60 million for the 12-month period ending 2017-12-31, per its 10-K filed 2020-03-27.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation · last filed 2020-03-27
- BRUKER CORPORATION adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2017 was $3.60M, a 176.92% increase from fiscal 2016.
- BRUKER CORPORATION adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2016 was $1.30M, a 40.91% decline from fiscal 2015.
- BRUKER CORPORATION adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2015 was $2.20M.
- BRUKER CORPORATION adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2011 was $200.00K, a 33.33% decline from fiscal 2010.
| Period end | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 12 month |
|---|---|
| 2017-12-31 | $3.60M 10-K · filed 2020-03-27 |
| 2016-12-31 | $1.30M 10-K · filed 2019-03-01 |
| 2015-12-31 | $2.20M 10-K · filed 2018-03-16 |
| 2011-12-31 | $200.00K 10-K · filed 2014-02-27 |
| 2010-12-31 | $300.00K 10-K · filed 2013-02-28 |
| 2009-12-31 | $600.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |